Last update March 10, 2026
Likely Compatibility
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Aspirin (anlgesic, antipyretic, > 300 mg/day) is also known as
Aspirin (anlgesic, antipyretic, > 300 mg/day) in other languages or writings:
Aspirin (anlgesic, antipyretic, > 300 mg/day) belongs to this group or family:
Main tradenames from several countries containing Aspirin (anlgesic, antipyretic, > 300 mg/day) in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by AELAMA of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory, and antipyretic properties. Usually administered orally, every 4-6 hours starting at 500 mg per day to relieve pain or fever.
ANALGESIC-ANTIPYRETIC USE, MEDIUM-HIGH DOSES, > 300 mg/day
Excreted in small amounts in breast milk (Datta 2017, Athavale 2013, Bailey 1982, Findlay 1981, Erickson 1979), but negligible when maternal doses of aspirin are less than 500 mg. (Datta 2017).
Although low plasma levels have been detected in infants (Unsworth 1987), no cases of Reye's syndrome due to aspirin in breast milk have been reported, and it is considered very unlikely to occur with isolated doses. (Shepherd 2020)
Various medical societies, experts, and expert consensus groups consider the occasional isolated use or antiplatelet doses of aspirin during breastfeeding to be safe or probably safe. (Datta 2017, Noviani 2016, Rowe 2013, Sachs 2013, Bell 2011, Chen 2010, Bar -Oz 2003, WHO 2002, Spigset 2000)
With maternal doses in the usual therapeutic analgesic-antipyretic-anti-inflammatory range, there are three older publications on side effects in infants: a highly dubious case of salicylic poisoning in the neonatal period (Clark 1981), thrombocytopenia in an infant (Terragna 1967), and a hemolytic crisis in a 23-day-old newborn with glucose-6-phosphate dehydrogenase deficiency. (Harley 1962)
Other studies have found no problems in infants whose mothers took aspirin. (Ito 1993)
For use in usual doses as an anti-inflammatory, analgesic, or antipyretic, safer alternatives are preferred during breastfeeding. (Noviani 2016, Davanzo 2014, Bloor 2013, Sachs 2013, Worthington 2013, Risser 2009, WHO 2002, Janssen 2000)
See below the information of this related product: